Proactive MD Acquires Leading Lung Cancer Liquid Biopsy Company
Healthcare innovator's latest acquisition to enhance lung health program for employers and patients PALO ALTO, CA, UNITED STATES, Febr ...
National Catholic Reporter1d
Q&A: Lung doctor who worked in the hospital now treating Pope Francis explains his illness
Pope Francis was in pain, swollen and walking very little. Italian pulmonologist Dr. Barbara Moscatelli says that this is ...
Novel antibiotic BTZ-043 can also target TB bacteria hiding in dead lung tissue
Every year, 10 million people contract tuberculosis (TB), a disease caused by the bacterium Mycobacterium tuberculosis (Mtb), and approximately 1.5 million patients succumb to the disease. Treatment ...
EurekAlert!2d
Novel antibiotic BTZ-043 also reaches tuberculosis bacteria hiding in dead lung tissue
Around 1.5 million patients succumb to the disease caused by the bacterium Mycobacterium tuberculosis (Mtb). The novel ...
HER2+ Non-Small Cell Lung Cancer Market is Predicted to Grow at a CAGR of 13.2% During the Study Period (2020–2034) | DelveInsight
The treatment landscape for HER2-positive NSCLC is rapidly evolving as research continues to reveal the genetic drivers of these tumors. Emerging therapies like Pyrotinib (Jiangsu HengRui Medicine), ...
Antibody therapy shrinks immunotherapy-resistant lung cancer tumors in mice
An investigational therapy significantly shrank lung cancer tumors that are notoriously resistant to treatment by encouraging ...
Targeted Oncology3d
Brahmer Considers First-Line Immunotherapy Options in Metastatic NSCLC
During a Case-Based Roundtable® event, Julie R. Brahmer, MD, MSC, reviewed the CheckMate 9LA, KEYNOTE-407, and POSEIDON ...